These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2085148)

  • 1. D-penicillamine metabolism: the role of transformation in blood plasma.
    Joyce DA; Murphy BR
    Agents Actions; 1990 Nov; 31(3-4):353-7. PubMed ID: 2085148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-penicillamine metabolism in an in-vivo model of inflamed synovium.
    Joyce DA; Forrest MJ; Brooks PM
    Agents Actions; 1988 Dec; 25(3-4):336-43. PubMed ID: 3218609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of albumin conjugates of D-penicillamine in rats.
    Joyce DA; Wade DN; Swanson BR
    Drug Metab Dispos; 1989; 17(2):208-11. PubMed ID: 2565212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.
    Joyce DA; Day RO
    Br J Clin Pharmacol; 1990 Oct; 30(4):511-7. PubMed ID: 2291865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro mechanism of oxidation of D-penicillamine in plasma.
    Joyce DA
    J Pharm Sci; 1991 Mar; 80(3):289-92. PubMed ID: 2051347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay for D-penicillamine-protein conjugate in human plasma utilising chemical reduction followed by high-performance liquid chromatography with gold/mercury electrochemical detection.
    Joyce DA; Wade DN
    J Chromatogr; 1988 Sep; 430(2):319-27. PubMed ID: 3235506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in response to D-penicillamine: pharmacokinetic insights.
    Joyce DA
    Agents Actions Suppl; 1993; 44():203-7. PubMed ID: 8372729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of albumin conjugates of D-penicillamine in humans.
    Joyce DA; Day RO; Murphy BR
    Drug Metab Dispos; 1991; 19(2):309-11. PubMed ID: 1676628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-penicillamine-induced angiopathy in rats. The effect of high dose D-penicillamine treatment on aortic permeability to albumin and on the ultrastructure of the vessel.
    Jensen BA; Chemnitz J; Christensen BC; Junker P; Lorenzen I
    Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):403-11. PubMed ID: 6666578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-penicillamine pharmacokinetics and action.
    Joyce DA
    Agents Actions Suppl; 1988; 24():197-206. PubMed ID: 3263758
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced intracellular delivery of the reactive oxygen species (ROS)-generating copper chelator D-penicillamine via a novel gelatin--D-penicillamine conjugate.
    Gupte A; Wadhwa S; Mumper RJ
    Bioconjug Chem; 2008 Jul; 19(7):1382-8. PubMed ID: 18570451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased binding of D-penicillamine to monocytes in rheumatoid arthritis.
    Watanabe H; Grimsley G; Major GA; Dawkins RL
    Clin Immunol Immunopathol; 1986 Apr; 39(1):173-8. PubMed ID: 3948434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of penicillamine in a female mongrel dog.
    Bergstrom RF; Kay RD; Wagner JG
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):603-21. PubMed ID: 7334461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of D-penicillamine in a patient with gastrointestinal progressive systemic sclerosis.
    Hendel L; Ammitzbøll T; Kreuzig F; Asboe-Hansen G; Worning H
    Scand J Rheumatol; 1986; 15(1):91-4. PubMed ID: 3961435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance studies of the binding of captopril and penicillamine by serum albumin.
    Keire DA; Mariappan SV; Peng J; Rabenstein DL
    Biochem Pharmacol; 1993 Sep; 46(6):1059-69. PubMed ID: 8216349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and metabolism of D- and L-penicillamine. 1. Blood level, transport and protein binding].
    Ruiz-Torres A
    Arzneimittelforschung; 1974 Jun; 24(6):914-7. PubMed ID: 4408088
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism and disposition of D-penicillamine in the DA-strain rat.
    Pilkington AE; Waring RH
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):99-104. PubMed ID: 3208797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and metabolism of D- and L-penicillamine. 3. Absorption, excretion, and metabolism].
    Ruiz-Torres A; Kürten I
    Arzneimittelforschung; 1974 Sep; 24(9):1258-61. PubMed ID: 4479787
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracellular delivery of the reactive oxygen species generating agent D-penicillamine upon conjugation to poly-L-glutamic acid.
    Wadhwa S; Mumper RJ
    Mol Pharm; 2010 Jun; 7(3):854-62. PubMed ID: 20349949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of disulfide formation. Comparison of chemical and enzyme-mediated reduction of penicillamine and captopril disulfides.
    Drummer OH; Routley L; Christophidis N
    Biochem Pharmacol; 1987 Apr; 36(8):1197-201. PubMed ID: 3297070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.